| Not Yet Recruiting | JY231(JY231) Injection for the Treatment of Refractory Autoimmune Diseases (ADs) Autoimmune Diseases | N/A | 2025-03-31 |
| Not Yet Recruiting | JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia B-ALL | N/A | 2025-03-31 |
| Not Yet Recruiting | JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma B-Non Hodgkin Lymphoma | N/A | 2025-03-01 |
| Recruiting | CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis Lupus Nephritis | EARLY_Phase 1 | 2025-01-31 |
| Suspended | A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia Relapsed/Refractory Acute Myeloid Leukemia(AML) | Phase 1 | 2025-01-08 |
| Recruiting | RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR Acute Myeloid Leukemia | Phase 4 | 2024-07-17 |
| Recruiting | Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Diffuse Large B-cell Lymphoma | EARLY_Phase 1 | 2023-11-16 |
| Recruiting | A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Ga Gaucher Disease Type I | N/A | 2023-11-15 |
| Recruiting | A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma Relapse/Refractory Multiple Myeloma | Phase 1 | 2023-10-20 |
| Completed | CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL Neoplasms, Hematologic Neoplasms, Neoplasms by Site | EARLY_Phase 1 | 2023-02-09 |
| Recruiting | Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Hematologic Disease | Phase 1 | 2022-08-04 |
| Recruiting | Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation Hematologic Diseases | Phase 1 | 2022-08-04 |
| Unknown | A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma | EARLY_Phase 1 | 2022-07-05 |
| Unknown | Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia AIDS Related Lymphoma and Lympholeukemia | Phase 1 | 2022-03-18 |
| Completed | A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Ma Acute Lymphoblastic Leukemia, Non-hodgkin Lymphoma | EARLY_Phase 1 | 2020-12-29 |
| Unknown | Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurren Relapsed and Refractory, Lymphoid Hematological Malignancies | Phase 1 / Phase 2 | 2020-11-20 |
| Completed | RD13-01 for Patients With r/r CD7+ T/NK Cell Hematologic Malignancies Hematologic Malignancies | Phase 1 | 2020-09-10 |
| Unknown | Peripheral Blood Mononuclear Cell Collection Protocol for UCART Cell Tumor Immunotherapy Study Peripheral Blood Mononuclear Cell | N/A | 2020-06-18 |
| Unknown | A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignanc Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma | EARLY_Phase 1 | 2020-02-05 |
| Recruiting | A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Mal Acute Lymphoblastic Leukemia, Non-hodgkin Lymphoma | EARLY_Phase 1 | 2020-01-08 |
| Recruiting | A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies Relapsed and Refractory, Lymphoid Hematological Malignancies | EARLY_Phase 1 | 2018-05-23 |